Volume 23, Supplement—December 2017
SUPPLEMENT ISSUE
Global Health Security Supplement
Prevent
Prioritizing Zoonoses for Global Health Capacity Building—Themes from One Health Zoonotic Disease Workshops in 7 Countries, 2014–2016
Stephanie J. Salyer
, Rachel Silver, Kerri Simone, and Casey Barton Behravesh
, Rachel Silver, Kerri Simone, and Casey Barton Behravesh
Table 2
Disease ranking criteria chosen by country during One Health Zoonotic Disease Prioritization workshops in 7 countries, 2014–2016*
| Disease ranking criteria | No. countries | Average assigned weight† (range) |
|---|---|---|
| Economic, environmental, and/or social impact | 7 | 0.193 (0.150–0.210) |
| Economic impact only | 3 | |
| Economic and/or social impact | 2 | |
| Economic, environmental, and/or social impact |
2 |
|
| Availability of interventions (i.e., vaccines and/or medical treatment) |
6 |
0.183 (0.160–0.200) |
| Epidemic/pandemic potential (and/or sustained transmission in humans) | 6 | 0.202 (0.170–0.220) |
| Human-to-human transmission potential | 5 | |
| History of previous outbreaks |
1 |
|
| Severity of disease in humans | 6 | 0.206 (0.180–0.230) |
| Case-fatality rate | 3 | |
| Morbidity and/or mortality rate |
3 |
|
| Presence of disease in country and/or region | 5 | 0.200 (0.170–0.210) |
| Human and/or animal cases of illness reported in country and/or region‡ | 4 | |
| Human or animal disease prevalence and distribution in country |
1 |
|
| Laboratory capacity/diagnostic testing capacity |
2 |
0.179 (0.160–0.198) |
| Existing multisectoral collaboration |
2 |
0.183 (0.170–0.195) |
| Bioterrorism potential |
1 |
0.194 |
| Mode of transmission | 1 | NA |
*Countries: Thailand, Kenya, Ethiopia, Azerbaijan, Cameroon, South Africa, Democratic Republic of the Congo. NA, not applicable.
†Thailand was excluded from this weighting analysis since the method used in this pilot workshop differed from the standard method adopted for all future workshops.
‡One country looked at human cases only; the other 3 looked at both human and animal cases.
Page created: November 20, 2017
Page updated: November 20, 2017
Page reviewed: November 20, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.